Furthermore, the comparison of hepatic indices revealed that women with NAFLD had higher AST/ALT (0.99 ± 0.37 vs. 0.73 ± 0.24, p < 0.001) and hepatic steatosis index (44.25 ± 6.06 vs. 42.93 ± 6.17, p = 0.01) levels, and lower ALD/NAFLD (-15.07 ± 5.04 vs. -7.71 ± 4.70, p < 0.001) index level compared to men with NAFLD (Table 4). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.